Industry appreciate Cabinet sanction of Rs 15000 crores for pharma PLI scheme
Stakeholders feel that it is a timely action towards making the industry self-reliant
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
BR Sikri
DoP forms expert committee to identify investment opportunities, bottlenecks in pharma industry
The committee needs to submit an action plan by November 6
Himachal Pradesh invites industry to sign MoU to set up units in proposed bulk drug park at Una
The State has identified 1,400 acres of land in Una for the bulk drug park and is promising competitive prices for land, power,…
Pharma industry appreciates modification in PLI scheme, seek more support
The industry also raises concerns related to brownfield investments, protection of indigenous manufacturing
NLEM 2020: Should patented drugs be included in it?
At the National Consultation Stakeholders meeting held in August for the revision of NLEM 2015, industry stakeholders requested…
Industry experts discuss regulatory roadmap for pharma industry
The stakeholders highlight the changes needed in the Indian regulatory system to meet changing demands, emerging concerns, at…
UPSIDA organises webinar to attract investors for proposed bulk drug park in Lalitpur
State authorities highlight initiatives that will be taken to create advantages for investors; stakeholders recommend measures to…
Mission Atma Nirbhar in pharma
BR Sikri, Chairman, FOPE, highlights that the pharma sector is key to India’s economic progress and ensuring its self-reliance in…
Govt gives validity extension of six months on registration certificate to pharma companies
Companies need to apply for a fresh registration certificate before the expiry of the existing certificate
PLI scheme guidelines evoke mix reviews from industry
Some laud the measures taken by the government while others list aspects that should have been considered under the scheme's…